Showing results (11-20 of 34) with videos related to
Sort By:
Pageof 4
Oncology Letters|March 15, 2019
Dual inhibition of MEK and p38 impairs tumor growth in <i>KRAS</i>-mutated non-small cell lung cancerNoriaki Sunaga, Yosuke Miura, Yusuke Tsukagoshi, et al.Current Neurovascular Research|July 2, 2019
Anti-VEGFR2 Antibody-modified Micelle for Triggered Drug Delivery and Effective Therapy of Choroidal NeovascularizationKei Takahashi, Tomomi Masuda, Mitsunori Harada, et al.Thoracic Cancer|June 13, 2020
Successful afatinib rechallenge in a patient with non-small cell lung cancer harboring EGFR G719C and S768I mutationsTomomi Masuda, Noriaki Sunaga, Norimitsu Kasahara, et al.Journal of Proteome Research|October 20, 2010
Identification of a novel type of CA19-9 carrier in human bile and sera of cancer patients: an implication of the involvement in nonsecretory exocytosisNaofumi Uozumi, Congxiao Gao, Tomoko Yoshioka, et al.Scientific Reports|May 1, 2015
The effect of triamcinolone acetonide on laser-induced choroidal neovascularization in mice using a hypoxia visualization bio-imaging probeShinsuke Takata, Tomomi Masuda, Shinsuke Nakamura, et al.Anticancer Research|March 6, 2020
Prospective Feasibility Study of Amrubicin and Bevacizumab Therapy for Patients With Previously Treated Advanced NSCLCHisao Imai, Kyoichi Kaira, Ichiro Naruse, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|January 23, 2021
Excess adiponectin in eyes with progressive ocular vascular diseasesAnri Nishinaka, Shinsuke Nakamura, Miruto Tanaka, et al.Current Neurovascular Research|November 9, 2016
Topical Diclofenac-Loaded Liposomes Ameliorate Laser-Induced Choroidal Neovascularization in Mice and Non-Human PrimatesMasamitsu Shimazawa, Yuki Inoue, Tomomi Masuda, et al.Investigative Ophthalmology & Visual Science|February 28, 2017
Apolipoprotein E2 and E3, but Not E4, Promote Retinal Pathologic NeovascularizationTomomi Masuda, Masamitsu Shimazawa, Yuhei Hashimoto, et al.International Journal of Clinical Oncology|August 13, 2015
Phase I dose escalation study of amrubicin plus paclitaxel in previously treated advanced non-small cell lung cancerKyoichi Kaira, Noriaki Sunaga, Hisao Imai, et al.Pageof 4